Valuation Ipca Laboratories Limited

Stocks

Delayed NSE India S.E. Other stock markets 09:15:15 29/07/2026 BST			5-day change	1st Jan Change
1,776.30 ^INR	-0.71%		-0.87%	+24.96%

06-26	Ipca Laboratories Limited agreed to acquire remaining 50.35% stake in Krebs Biochemicals & Industries Limited for INR 612 million.	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	270,385	205,589	313,934	381,038	406,231	453,877	-	-
Change	-	-23.96%	52.7%	21.38%	6.61%	11.73%	-	-
Enterprise Value (EV) ¹	275,070	201,870	325,349	391,231	408,673	442,053	430,217	423,046
Change	-	-26.61%	61.17%	20.25%	4.46%	8.17%	-2.68%	-1.67%
P/E	30.6x	43.6x	57.4x	51.6x	35.6x	32.5x	27.3x	23.3x
PBR	4.92x	2.58x	4.96x	5.48x	5.04x	4.82x	4.16x	3.49x
PEG	-	-0.9x	3.6x	1.5x	0.7x	1.5x	1.4x	1.4x
Capitalization / Revenue	4.64x	3.29x	4.07x	4.26x	4.21x	4.21x	3.78x	3.41x
EV / Revenue	4.72x	3.23x	4.22x	4.38x	4.24x	4.1x	3.58x	3.18x
EV / EBITDA	21x	21.8x	24.6x	22.7x	20.7x	18.8x	15.8x	13.6x
EV / EBIT	25.6x	30.3x	33.8x	29.5x	26.2x	23.4x	19.6x	16.5x
EV / FCF	72.9x	64.8x	60.9x	71.7x	83.5x	46.6x	39.1x	28.9x
FCF Yield	1.37%	1.54%	1.64%	1.4%	1.2%	2.15%	2.56%	3.46%
Dividend per Share ²	8	4	4	2	6	5.792	6.258	6.25
Rate of return	0.75%	0.49%	0.32%	0.13%	0.37%	0.32%	0.35%	0.35%
EPS ²	34.85	18.58	21.57	29.08	44.98	54.99	65.61	76.72
Distribution rate	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.54%	8.15%
Net sales ¹	58,298	62,443	77,050	89,396	96,463	107,687	120,078	132,985
EBITDA ¹	13,073	9,268	13,212	17,261	19,786	23,560	27,251	31,158
EBIT ¹	10,748	6,652	9,639	13,283	15,604	18,921	21,987	25,600
Net income ¹	8,841	4,713	5,474	7,377	11,411	14,000	16,697	19,470
Net Debt ¹	4,685	-3,720	11,415	10,193	2,442	-11,824	-23,660	-30,831
Reference price ²	1,065.75	810.35	1,237.40	1,501.90	1,601.20	1,789.00	1,789.00	1,789.00
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	24/05/22	29/05/23	29/05/24	29/05/25	29/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IPCA LABORATORIES LIMITED	32.53x	4.1x	18.76x	0.32%	4.75B
ELI LILLY AND COMPANY	36.25x	12.94x	27.18x	0.55%	1,089B
JOHNSON & JOHNSON	28.59x	6.53x	18.09x	2.01%	643B
ABBVIE INC.	33.13x	7.75x	15.94x	2.61%	465B
ROCHE HOLDING AG	20.2x	4.86x	12.04x	2.72%	359B
NOVARTIS AG	22.65x	5.84x	14.57x	2.74%	303B
ASTRAZENECA PLC	22.03x	4.53x	12.8x	1.93%	267B
NOVO NORDISK A/S	14.79x	5.48x	11.3x	3.38%	226B
AMGEN INC.	25.81x	6.73x	11.86x	2.57%	212B
GILEAD SCIENCES, INC.	-48.4x	5.8x	32.01x	2.45%	167B
Average	18.76x	6.46x	17.46x	2.13%	373.59B
Weighted average by Cap.	25.20x	8.10x	19.08x	1.92%